Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Tuberculosis and COVID-19 in 2020: lessons from the past viral outbreaks and possible future outcomes

Radu Crisan-Dabija, Cristina Grigorescu, Cristina-Alice Pavel, Bogdan Artene, View ORCID ProfileIolanda Valentina Popa, Andrei Cernomaz, View ORCID ProfileAlexandru Burlacu
doi: https://doi.org/10.1101/2020.04.28.20082917
Radu Crisan-Dabija
1University of Medicine and Pharmacy “Grigore T. Popa” Iasi, Pulmonology Department, Head of Clinic of Pulmonary Diseases Iasi;
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: radu.dabija@umfiasi.ro
Cristina Grigorescu
2University of Medicine and Pharmacy “Grigore T. Popa” Iasi, Depatment Thoracic Surgery, Clinic of Thoracic Surgery Iasi, Hospital of Pulmonary Diseases Iasi;
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cpislariu@hotmail.com
Cristina-Alice Pavel
3Clinic of Pulmonary Diseases Iasi, Romania;
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: alice.tarus@yahoo.com
Bogdan Artene
4Department of Interventional Cardiology - Cardiovascular Diseases Institute, Iasi, Romania;
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bogdan.artene@yahoo.com
Iolanda Valentina Popa
5Institute of Gastroenterology and Hepatology, Iasi, Romania, and ‘Grigore T. Popa’ University of Medicine, Iasi, Romania;
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Iolanda Valentina Popa
  • For correspondence: iolivp@gmail.com iolivp@gmail.com
Andrei Cernomaz
6University of Medicine and Pharmacy “Grigore T. Popa” Iasi, Pulmonology Department, Institute of Oncology Iasi,
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: a_cernomaz@yahoo.com
Alexandru Burlacu
7Head of Department of Interventional Cardiology Cardiovascular Diseases Institute, and “Grigore T. Popa” University of Medicine, Iasi, Romania; ;
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexandru Burlacu
  • For correspondence: alexandru.burlacu@umfiasi.ro alburlacu@yahoo.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The threat of contagious infectious diseases is constantly evolving, as demographic explosion, travel globalization and changes in human lifestyle increase the risk of spreading pathogens, leading to accelerated changes in disease landscape. Of particular interest is the aftermath of superimposing viral epidemics (especially SARS-CoV-2) over long-standing diseases, such as tuberculosis (TB), which remains a significant disease for public health worldwide and especially in emerging economies.

Methods and Results PubMed electronic database was requested for relevant articles linking TB, influenza and SARS-CoV viruses and subsequently assessed eligibility according to inclusion criteria. Using a data mining approach, we also queried the COVID-19 Open Research Dataset (CORD-19). We aimed to answer the following questions: What can be learned from other coronavirus outbreaks (with a focus on TB patients)? Is coinfection (TB and SARS-CoV-2) more severe? Is there a vaccine for SARS-CoV-2? How does the TB vaccine affect COVID19? How does one diagnosis affect the other?

Discussions Few essential elements about TB and SARS-CoV coinfections were discussed. First, lessons from the past outbreaks (other coronaviruses), as well as influenza pandemic / seasonal outbreaks have taught the importance of infection control to avoid the severe impact on TB patients. Second, although challenging due to data scarcity, investigating the pathological pathways linking TB and SARS-CoV-2 leads to the idea that their coexistence might yield a more severe clinical evolution. Finally, we addressed the issues of vaccination and diagnostic reliability in the context of coinfection.

Conclusions Because viral respiratory infections and TB impede the host’s immune responses, it can be assumed that their harmful synergism may contribute to more severe clinical evolution. Despite the rapidly growing number of cases, the data needed to predict the impact of the COVID-19 pandemic on patients with latent TB and TB sequelae still lies ahead.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by the Romanian Academy of Medical Sciences and European Regional Development Fund, MySMIS 107124: Funding Contract 2/Axa 1/31.07.2017/ 107124 SMIS

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data used to support the findings of this study are available from the corresponding author upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted May 01, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Tuberculosis and COVID-19 in 2020: lessons from the past viral outbreaks and possible future outcomes
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Tuberculosis and COVID-19 in 2020: lessons from the past viral outbreaks and possible future outcomes
Radu Crisan-Dabija, Cristina Grigorescu, Cristina-Alice Pavel, Bogdan Artene, Iolanda Valentina Popa, Andrei Cernomaz, Alexandru Burlacu
medRxiv 2020.04.28.20082917; doi: https://doi.org/10.1101/2020.04.28.20082917
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Tuberculosis and COVID-19 in 2020: lessons from the past viral outbreaks and possible future outcomes
Radu Crisan-Dabija, Cristina Grigorescu, Cristina-Alice Pavel, Bogdan Artene, Iolanda Valentina Popa, Andrei Cernomaz, Alexandru Burlacu
medRxiv 2020.04.28.20082917; doi: https://doi.org/10.1101/2020.04.28.20082917

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Respiratory Medicine
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (580)
  • Anesthesia (141)
  • Cardiovascular Medicine (1965)
  • Dentistry and Oral Medicine (253)
  • Dermatology (187)
  • Emergency Medicine (336)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (704)
  • Epidemiology (11124)
  • Forensic Medicine (8)
  • Gastroenterology (630)
  • Genetic and Genomic Medicine (3202)
  • Geriatric Medicine (310)
  • Health Economics (567)
  • Health Informatics (2051)
  • Health Policy (864)
  • Health Systems and Quality Improvement (790)
  • Hematology (310)
  • HIV/AIDS (686)
  • Infectious Diseases (except HIV/AIDS) (12745)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (319)
  • Medical Ethics (92)
  • Nephrology (339)
  • Neurology (3004)
  • Nursing (167)
  • Nutrition (466)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1563)
  • Ophthalmology (478)
  • Orthopedics (186)
  • Otolaryngology (266)
  • Pain Medicine (203)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (915)
  • Pharmacology and Therapeutics (387)
  • Primary Care Research (356)
  • Psychiatry and Clinical Psychology (2807)
  • Public and Global Health (5616)
  • Radiology and Imaging (1102)
  • Rehabilitation Medicine and Physical Therapy (637)
  • Respiratory Medicine (764)
  • Rheumatology (342)
  • Sexual and Reproductive Health (316)
  • Sports Medicine (290)
  • Surgery (348)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)